ATM and cancer: Moreover, next generation sequencing (NGS) analysis revealed that ATM is among the most aberrant gene in sporadic cancer (as shown by the COSMIC database), and that loss of heterozygosity in the region of the ATM has been detected in approximately 40% of human sporadic BC [13,14,15].